Clinical Trial Update: HybridAPC for Gastric Mucosal Ablation in Obese Patients. [NA]

View source ↗

Summary

A clinical trial evaluating HybridAPC for gastric mucosal ablation in obese patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• HybridAPC

Snippet

Sponsor: Erbe Elektromedizin GmbH | Conditions: Obesity, Adiposity | NA | Status: COMPLETED